{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T03:31:07Z","timestamp":1787542267070,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2022JJ30861"],"award-info":[{"award-number":["2022JJ30861"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.intimp.2025.114558","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T15:40:40Z","timestamp":1743522040000},"page":"114558","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Antibody prevalence and validation of APE2 and ACES in epilepsy patients with suspected autoimmune origin: A retrospective study"],"prefix":"10.1016","volume":"154","author":[{"given":"Yuwei","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binhong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianxiang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.intimp.2025.114558_bb0005","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1093\/clinchem\/hvaa254","article-title":"Neural antibody testing in patients with suspected autoimmune encephalitis","volume":"66","author":"Budhram","year":"2020","journal-title":"Clin. Chem."},{"issue":"3","key":"10.1016\/j.intimp.2025.114558_bb0010","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1172\/JCI125178","article-title":"Autoimmune seizures and epilepsy","volume":"129","author":"Geis","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.intimp.2025.114558_bb0015","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/epi.12127","article-title":"Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy","volume":"54","author":"Brenner","year":"2013","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.intimp.2025.114558_bb0020","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/jamaneurol.2016.5429","article-title":"Neurological autoantibody prevalence in epilepsy of unknown etiology","volume":"74","author":"Dubey","year":"2017","journal-title":"JAMA Neurol."},{"issue":"4","key":"10.1016\/j.intimp.2025.114558_bb0025","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/ana.21917","article-title":"Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis","volume":"67","author":"Malter","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.intimp.2025.114558_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111763","article-title":"Performance of assessment tools in predicting neural autoantibody positivity in patients with seizures","volume":"130","author":"Peng","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"7","key":"10.1016\/j.intimp.2025.114558_bb0035","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1111\/epi.17238","article-title":"\u201cobvious\u201d indications for neural antibody testing in epilepsy or seizures: the ONES checklist","volume":"63","author":"Chang","year":"2022","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.intimp.2025.114558_bb0040","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/epi.16571","article-title":"Acute symptomatic seizures secondary to autoimmune encephalitis and autoimmune-associated epilepsy: conceptual definitions","volume":"61","author":"Steriade","year":"2020","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.intimp.2025.114558_bb0045","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/ana.26013","article-title":"Antibodies contributing to focal epilepsy signs and symptoms score","volume":"89","author":"de Bruijn","year":"2021","journal-title":"Ann. Neurol."},{"issue":"24","key":"10.1016\/j.intimp.2025.114558_bb0050","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1097\/CM9.0000000000001701","article-title":"Antibody prevalence and immunotherapy response in Chinese patients with epilepsy and encephalopathy scores for patients with different neuronal surface antibodies","volume":"134","author":"Jia","year":"2021","journal-title":"Chin. Med. J."},{"issue":"4","key":"10.1016\/j.intimp.2025.114558_bb0055","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S1474-4422(21)00023-5","article-title":"Epilepsy in China: major progress in the past two decades","volume":"20","author":"Ding","year":"2021","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.intimp.2025.114558_bb0060","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/epi.14649","article-title":"Antibody prevalence in epilepsy and encephalopathy score: increased specificity and applicability","volume":"60","author":"Dubey","year":"2019","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.intimp.2025.114558_bb0065","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/epi.13797","article-title":"Predictive models in the diagnosis and treatment of autoimmune epilepsy","volume":"58","author":"Dubey","year":"2017","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.intimp.2025.114558_bb0070","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/epi.17478","article-title":"Acute symptomatic seizures, epilepsy, and autoimmune encephalitis: clarifying terminology in neural antibody-associated disease","volume":"64","author":"Budhram","year":"2023","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.intimp.2025.114558_bb0075","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"issue":"11","key":"10.1016\/j.intimp.2025.114558_bb0080","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1212\/01.wnl.0000187129.66353.13","article-title":"Serum antibodies in epilepsy and seizure-associated disorders","volume":"65","author":"McKnight","year":"2005","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.intimp.2025.114558_bb0085","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1007\/s00415-022-10973-8","article-title":"The importance of tissue-based assay in the diagnosis of autoimmune encephalitis","volume":"269","author":"Gadoth","year":"2022","journal-title":"J. Neurol."},{"key":"10.1016\/j.intimp.2025.114558_bb0090","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1136\/jnnp-2022-329195","article-title":"Epileptic phenotypes in autoimmune encephalitis: from acute symptomatic seizures to autoimmune-associated epilepsy","volume":"93","author":"Matricardi","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.intimp.2025.114558_bb0095","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.3389\/fimmu.2018.02708","article-title":"Management of Autoimmune Encephalitis: an observational monocentric study of 38 patients","volume":"9","author":"Macher","year":"2018","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2025.114558_bb0100","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S1474-4422(23)00083-2","article-title":"Diagnostic criteria for autoimmune encephalitis: utility and pitfalls for antibody-negative disease","volume":"22","author":"Dalmau","year":"2023","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.intimp.2025.114558_bb0105","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/epi.16807","article-title":"Seizures in autoimmune encephalitis-a systematic review and quantitative synthesis","volume":"62","author":"Yeshokumar","year":"2021","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.intimp.2025.114558_bb0110","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00234-018-1976-6","article-title":"MRI findings in glutamic acid decarboxylase associated autoimmune epilepsy","volume":"60","author":"Fredriksen","year":"2018","journal-title":"Neuroradiology"},{"key":"10.1016\/j.intimp.2025.114558_bb0115","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.seizure.2020.05.008","article-title":"Low rate of glutamic acid decarboxylase 65 (GAD-65) antibodies in chronic epilepsy","volume":"80","author":"Tizazu","year":"2020","journal-title":"Seizure"},{"issue":"6","key":"10.1016\/j.intimp.2025.114558_bb0120","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1007\/s00415-021-10894-y","article-title":"When should we test patients with epilepsy for autoimmune antibodies? Results from a French retrospective single center study","volume":"269","author":"Kambadja","year":"2022","journal-title":"J. Neurol."},{"issue":"10","key":"10.1016\/j.intimp.2025.114558_bb0125","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/cns.13707","article-title":"Recognition of seizure semiology and semiquantitative FDG-PET analysis of anti-LGI1 encephalitis","volume":"27","author":"Li","year":"2021","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.intimp.2025.114558_bb0130","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.seizure.2021.09.007","article-title":"Predictors and prognoses of epilepsy after anti-neuronal antibody-positive autoimmune encephalitis","volume":"92","author":"Chen","year":"2021","journal-title":"Seizure"},{"key":"10.1016\/j.intimp.2025.114558_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2023.109403","article-title":"Validation of different predictive scoring scales in patients with new-onset epileptic seizures or epilepsy related to neuronal surface antibody-mediated autoimmune encephalitis","volume":"147","author":"Duan","year":"2023","journal-title":"Epilepsy Behav."},{"issue":"11","key":"10.1016\/j.intimp.2025.114558_bb0140","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/jnnp-2020-323841","article-title":"Epileptic seizures of suspected autoimmune origin: a multicentre retrospective study","volume":"91","author":"Bozzetti","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"7","key":"10.1016\/j.intimp.2025.114558_bb0145","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1111\/epi.17245","article-title":"Long-term seizure outcomes in patients with autoimmune encephalitis: a prospective observational registry study update","volume":"63","author":"Liu","year":"2022","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.intimp.2025.114558_bb0150","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s13311-019-00750-3","article-title":"Autoimmune Epilepsy","volume":"16","author":"Husari","year":"2019","journal-title":"Neurotherapeutics"},{"issue":"8","key":"10.1016\/j.intimp.2025.114558_bb0155","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/j.mayocp.2021.02.019","article-title":"Autoimmune encephalitis-related seizures and epilepsy: diagnostic and therapeutic approaches","volume":"96","author":"Chen","year":"2021","journal-title":"Mayo Clin. Proc."},{"issue":"3","key":"10.1016\/j.intimp.2025.114558_bb0160","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1177\/1550059415595907","article-title":"Are there any specific EEG findings in autoimmune epilepsies?","volume":"47","author":"Baysal-Kirac","year":"2016","journal-title":"Clin. EEG Neurosci."},{"issue":"12","key":"10.1016\/j.intimp.2025.114558_bb0165","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1111\/epi.13929","article-title":"Seizure outcomes in patients with anti-NMDAR encephalitis: a follow-up study","volume":"58","author":"Liu","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.intimp.2025.114558_bb0170","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jocn.2019.07.049","article-title":"Clinical features and long-term outcomes of seizures associated with autoimmune encephalitis: a follow-up study in East China","volume":"68","author":"Yao","year":"2019","journal-title":"J. Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.intimp.2025.114558_bb0175","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/jnnp-2024-334285","article-title":"Prognosis prediction and immunotherapy optimisation for cryptogenic new-onset refractory status epilepticus","volume":"96","author":"Jang","year":"2024","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.intimp.2025.114558_bb0180","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jns.2017.03.020","article-title":"Global brain atrophy and metabolic dysfunction in LGI1 encephalitis: a prospective multimodal MRI study","volume":"376","author":"Szots","year":"2017","journal-title":"J. Neurol. Sci."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692500548X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692500548X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T20:02:50Z","timestamp":1744488170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757692500548X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":36,"alternative-id":["S156757692500548X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114558","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibody prevalence and validation of APE2 and ACES in epilepsy patients with suspected autoimmune origin: A retrospective study","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114558","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114558"}}